Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal Medical Dialogues Bureau26 Nov 2019 9:30 AM ISTIn September 2018, the USD three billion drug-maker, Aurobindo Pharma said its US subsidiary entered into an agreement to acquire commercial...
Bristol-Myers to sell blockbuster Otezla for its $74 billion merger with Celgene Medical Dialogues Bureau26 Jun 2019 9:00 AM ISTBristol-Myers announced its plans to buy Celgene in a cash-and-stock deal in early January to bring together the companies that specialize in oncology...
Roche, Spark Therapeutics $4.3 billion deal delayed again amid US, UK scrutiny Farhat Nasim10 Jun 2019 9:30 AM ISTRoche said on Monday that both companies received a request for more information from the U.S. Federal Trade Commission in connection with the FTC's...